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2Abstract
Heparan sulfate 6-O-endosufatases Sulf1 and Sulf2 hydrolyze the 6-O-sulfate of the
glucosamine residues in heparin and heparan sulfate, thereby regulating multiple
signaling pathways. A previous study reported that human Sulf1 and Sulf2 were
proteolytically processed in a manner sensitive to a furin inhibitor. However, the exact
sites of cleavage, the sequence motifs for proteolysis, and the effect of the cleavage on
enzyme activity remain unknown. Here we show that the cleavage of rat Sulf2 (also
called SulfFP2) occurs at 2 arginine residues, 543 and 570, in the hydrophilic domain.
Both sites reside in the consensus sequence for the cleavage by furin-type proprotein
convertases, and the consensus motifs are essential for cleavages. The cleavage at
arginine 570 is sensitive to a furin inhibitor. Furthermore, the uncleavable form of
SulfFP2 shows sulfatase activity comparable to the cleavable SulfFP2, indicating that
the cleavage is not indispensable for activation of SulfFP2.
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3Introduction
Heparan sulfate (HS) regulates cell differentiation, proliferation, and migration by
interacting with a wide variety of proteins, including growth factors, morphogens, and
their receptors, as well as with extracellular matrix molecules [1-4]. HS is extensively
modified by nonuniform epimerization and sulfation, giving rise to enormous structural
heterogeneity in its chain [1-4]. In particular, the sulfation patterns of HS define the
specificity and affinity of the ligand binding and play a role in the functional
diversification of HS [1-4].
Sulfatases comprise a family of enzymes that hydrolyze sulfate ester bonds in a
wide variety of biological compounds [5]. All the known eukaryotic sulfatases have a
conserved cysteine residue in their catalytic domains that is posttranslationally
converted to a Cα-formylglycine [5]. This modification carried out by sulfatase
modifying factor 1 (Sumf1) is essential for enzyme activity [6-7]. Recently, a new class
of sulfatases has been reported. This class comprises 2 orthologues in the human, mouse,
rat, and quail genomes: Sulfatase 1 (Sulf1, also called Sulfatase FP1 [SulfFP1]) and
Sulfatase 2 (Sulf2, also called SulfFP2) [8-13]. Sulfs comprise a putative signal
sequence at the N terminus, an enzyme catalytic domain in the N-terminal region, a
hydrophilic domain in the middle portion, and a C-terminal domain [8-12; see 13 for
review]. Sulfs catalyze hydrolysis of the 6-O-sulfate of the glucosamine residues in
intact heparin and HS at neutral pH [8-9, 12, 14]. As a result of 6-O-desulfation, they
regulate multiple signaling pathways positively or negatively [8-9, 12-17]. Morimoto et
al. [9] reported that human Sulfs underwent proteolytic cleavage that was sensitive to a
4furin inhibitor. However, exactly where the cleavage occurs, what sequence motifs are
present in the cleavage sites, whether all the proteolysis is mediated by furin, and
whether the cleavage is necessary for the enzyme activity remain unknown.
Furin and proprotein convertases (PCs) form a family of specialized
endoproteinases that cleave the multibasic motifs in proprotein substrates in the
secretory pathway [18-19]. Their substrates include growth factors, hormones,
neuropeptides, and extracellular matrix proteins, and this posttranslational processing
transforms inactive precursors into active proteins and peptides [18-19]. The consensus
sequence of the cleavage by furin and PCs is R/K-X-R/K-X-R/K-R-↓-X (R, K, X, and
↓ denote arginine, lysine, any amino acid, and the cleavage site, respectively), in which
the last arginine residue is essential and at least 2 of the 3 R/K residues should be
arginine or lysine [18]. Recently, Duckert et al. [20] developed a method to predict the
cleavage sites for PCs on the basis of artificial neural networks.
In this study, we determined the cleavage sites of SulfFP2 by Edman degradation
sequencing of the fragments of the secreted SulfFP2 protein. We found that there were
consensus sequences for the cleavage and that these sequences were required for
proteolysis. We also found that the cleavage was not indispensable for SulfFP2
activation.
Materials and methods
Expression constructs. The coding region of rat SulfFP2 [11] tagged with a Myc-
His epitope at its C terminus was subcloned into a pCEP4 vector (Invitrogen, Carlsbad,
5CA, USA). Mutations were introduced using PCR. Mouse Sumf1 cDNA (UniGene ID:
2828521) was obtained using RT-PCR and inserted into a pCAGGS vector (a kind gift
of J. Miyazaki, Osaka University).  
Cell culture and transfection. The 293EBNA cells (Invitrogen) were transfected
using LipofectAMINE 2000 (Invitrogen). After the cells were cultured in Opti-MEM I
(Invitrogen) without fetal bovine serum for 3 days, the conditioned medium was
analyzed. In some experiments, the cells were incubated with 10 µM decanoyl-Arg-Val-
Lys-Arg-chloromethylketone (dec-RVKR-CMK; Bachem, Bubendorf, Switzerland)
after transfection.
Protein sequencing. SulfFP2 protein in the conditioned medium of 293EBNA cells
transfected with pCEP4-SulfFP2-MycHis was purified using a cation exchange column
(HiTrap SP HP; GE Healthcare Bio-Sciences, Piscataway, NJ, USA) on a BioLogic
DuoFlow system (Bio-Rad, Hercules, CA, USA). After washing with 50 mM HEPES-
NaOH buffer (pH 7.0) containing 0.1 M NaCl, eluents were obtained with a linear
gradient of 0.1 M to 1.0 M NaCl. The fractions containing SulfFP2-MycHis protein,
eluting at 0.64-0.82 M NaCl, were pooled and subjected to SDS-PAGE. After being
blotted to an Immobilon PVDF membrane (Millipore, Billerica, MA, USA) and stained
with Coomassie Brilliant Blue R-250 solution (Bio-Rad), the bands were cut and
subjected to Edman degradation gas-phase protein sequencing using a protein sequencer
(PPSQ-23; Shimadzu, Kyoto, Japan).
Antibody production. Two sequences in the hydrophilic domain of rat SulfFP2,
amino acid residues 421-564 (designated as SulfFP2A) and 576-724 (SulfFP2B), were
6separately subcloned into a pBAD/His prokaryotic expression vector (Invitrogen). The
recombinant SulfFP2 proteins were produced in the E. coli and then purified using a
HisTrap kit (GE Healthcare Bio-Sciences). Antibodies were raised by immunizing
rabbits with the resultant proteins (TransGenic, Kumamoto, Japan).
Western blot analysis. The conditioned medium was concentrated by
trichloroacetate precipitation, resolved by SDS-PAGE, and transferred to an Immobilon
PVDF membrane. To remove glycosylation, the concentrated conditioned medium was
incubated with 0.1 U/µl N-glycosidase F (Roche Diagnostics, Basel, Switzerland) at
37°C for 16 h before SDS-PAGE. The membrane was incubated with anti-SulfFP2A
(1:500), anti-SulfFP2B (1:500), or anti-Myc mouse monoclonal antibody (1:2,000;
Invitrogen), and then with either horseradish peroxidase-conjugated anti-rabbit IgG
(1:5,000; Bio-Rad) or anti-mouse IgG (1:5,000; Chemicon, Temecula, CA, USA)
antibodies. After washing, chemiluminescence reaction was carried out using an ECL
kit (GE Healthcare Bio-Sciences), and the membrane was exposed to X-ray films.
Bioinformatics. Amino acid sequences were retrieved from the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/). Multiple sequence
alignment was done using ClustalW (http://www.clustal.org/). Cleavage sites for a
signal peptidase and furin/PCs were predicted using the SignalP 3.0 server
(http://www.cbs.dtu.dk/services/SignalP/) and the ProP 1.0 server
(http://www.cbs.dtu.dk/services/ProP), respectively.
Enzyme assay. Sulfatase activity was measured using a fluorogenic substrate, 4-
methylumbelliferyl sulfate (4-MUS; Sigma-Aldrich, St. Louis, MO, USA). The
7conditioned medium of 293EBNA cells transfected with pCEP4-SulfFP2-MycHis or its
mutant forms in combination with pCAGGS-Sumf1 was concentrated 30-fold using a
Microcon YM-30 (Millipore). The medium was incubated with 10 mM 4-MUS, 10 mM
MgCl2, 150 mM NaCl, and 0.01% bovine serum albumin in 50 mM sodium acetate
buffer (pH 7.4) in a total volume of 50 µl at 37°C for 24 h. To terminate the reaction,
100 µl of 0.5 M Na2CO3/NaHCO3 (pH 10.7) was added to a 20-µl aliquot of the reaction
mixture, and the fluorescence of 4-methylumbelliferone was measured using
SpectraMax M2 (Molecular Devices, Sunnyvale, CA, USA), with an excitation
wavelength of 360 nm and an emission wavelength of 460 nm. Because the 293EBNA
cells had endogenous sulfatase activity of unknown origin, the sulfatase activity in the
conditioned medium from the β-galactosidase-transfected cells was subtracted.
To measure endosulfatase activity, the concentrated conditioned medium (5 µl)
was incubated with 10 µg heparin, 200 mM NaCl, and 10 mM MgCl2 in 10 mM Tris-
HCl buffer (pH 7.5) in a total volume of 10 µl at 37°C for 24 h. The mixture was heated
at 95°C for 2 min and then incubated with 10 µl 40 mM HEPES-NaOH (pH 7.0)
containing 2 mM calcium acetate, 1 mIU heparinase I (Sigma-Aldrich), 1 mIU
heparitinase I (Seikagaku, Tokyo, Japan), and 1 mIU heparitinase II (Seikagaku) at
37°C for 24 h. After the digestion was stopped by heating at 95°C for 2 min and the
mixture cleaned using an Ultrafree-MC filter (Millipore), unsaturated disaccharides
were analyzed by reversed-phase ion-pair chromatography essentially as previously
reported [21]. A gradient was applied at a flow rate of 1.1 ml/min on a Senshu Pak
Docosil (4.6 x 150 mm, particle size 5 µm; Senshu Scientific, Tokyo, Japan) at 55°C
8using a HPLC system (Alliance UV system 2695/2487; Waters, Massachusetts, USA).
The eluents were as follows: A, H2O; B, 0.2 M NaCl; C, 10 mM tetra-n-butylammonium
hydrogen sulfate; and D, 50% acetonitrile. The gradient of eluent B was as follows: 0-
10 min, 1-4%; 10-11 min, 4-15%; 11-20 min, 15-25%; 20-22 min, 25-53%; 22-29 min,
53%. The proportions of eluent C and D were constant at 12% and 17%, respectively.
The effluent was monitored spectrophotometrically (absorbance at 232 nm), and
disaccharide peaks were identified and quantified by comparison with the following
authentic unsaturated disaccharide markers: unsaturated HS/HEP-disaccharide mixture
(H Mix; Seikagaku), ΔUA2S-GlcNAc and ΔUA2S-GlcNAc6S (Dextra Laboratories,
Reading, UK). The chromatogram was analyzed using Empower software (Waters).
Results and discussion
Determination of the N-terminal sequences of the secreted SulfFP2 protein
To begin to examine the molecular mechanism by which SulfFP2 is cleaved, we
first determined the cleavage site(s) by directly determining the N-terminal sequence(s)
of the processed fragments. After 293EBNA cells were transfected with pCEP4-
SulfFP2-MycHis and cultured in a serum-free medium for 3 days, SulfFP2 protein in the
conditioned medium was purified using a cation exchange column. The purified protein
was subjected to SDS-PAGE, blotted onto a PVDF membrane, stained with Coomassie
Brilliant Blue, and analyzed.
Edman degradation of the ~90 kDa fragment yielded a mixture of 2 sequences of
FLSYPRLKGR and DRRNIRPNII, found at the 25-34 and 38-47 residues of SulfFP2
9(Fig. 1A and B), respectively. Thus, SulfFP2 was cleaved at 2 different sites near its N
terminus: between Ala24 and Phe25 and between Arg37 and Asp38. The former matched the
signal peptide cleavage site predicted using the SignalP 3.0 server, whereas the latter
matched the consensus sequence of the cleavage site by furin family PCs [17, 19].
These findings suggest that SulfFP2 underwent proteolytic cleavage at Ala24 by signal
peptidases and at Arg37 by PCs.
Next, Edman degradation of ~51 kDa, ~48 kDa, and ~43 kDa yielded the same
sequence of SVAIEVDGEV, found at 544-553 residues of SulfFP2, indicating that all
these fragments were generated by the cleavage between Arg543 and Ser544. In addition,
minor products of Edman degradation in the 48-kDa fragment indicated the existence of
a cleavage between Arg570 and His571. The amino acid sequences preceding these 2
cleavage sites (RNRSIR and RNLTKR) matched the consensus sequence of the
cleavage by furin-type PCs (Fig. 1C) predicted by the ProP program [20]. Thus,
SulfFP2 protein underwent cleavage at 2 sites in the hydrophilic domain. Moreover,
high conservation of the consensus sequences between many vertebrate species suggests
that the cleavage mechanism is evolutionarily preserved.
Proteolytic processing of SulfFP2 protein
We next examined SulfFP2 processing by western blot analysis. First, we
examined SulfFP2 protein in the cell lysate and conditioned medium using anti-Myc
antibody, which recognized the C terminus of SulfFP2-MycHis protein. This antibody
detected a band of ~130-kDa in the cell lysate (fragments F1+F2; see Fig. 2B for the
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names of the SulfFP2 fragments), whereas a very faint band of similar size was detected
in the conditioned medium after long exposure to X-ray films (Fig. 2A; data not shown).
The sizes of both bands were reduced to 102 kDa after treatment with N-glycosidase F
(data not shown). Because the calculated molecular mass of SulfFP2-MycHis after
signal peptide cleavage (100.1 kDa) was close to the observed size of the N-
glycosidase-treated protein (102-kDa), the 130-kDa bands appeared to represent the
full-length protein. In addition, processed fragments of 51 kDa and 48 kDa (fragments
C1 and C2) were detected in both the cell lysate and the conditioned medium (Fig. 2A).
N-glycosidase F treatment reduced their sizes to 41 kDa and 38 kDa, respectively (data
not shown; see also Fig. 2A), indicating that these C-terminal fragments were N-
glycosylated. Furthermore, a weak band of ~20-kDa (fragment C3) was detected in the
conditioned medium (Fig. 2A); the size of this band was reduced to less than 10 kDa
after N-glycosidase F treatment (data not shown). These findings indicated that some
additional processing occurred near the C terminus.
To examine how SulfFP2 protein was processed, we generated polyclonal
antibodies that specifically recognized the N-terminal and C-terminal fragments of
SulfFP2. We selected 2 sequences in the hydrophilic domain of SulfFP2: the N-terminal
half (designated as SulfFP2A) containing residues 421-564 and the C-terminal half
(SulfFP2B) containing residues 576-724 (Fig. 2B). We produced the recombinant
proteins in E. coli and immunized rabbits. Western blotting of the conditioned medium
with anti-SulfFP2A antibody detected multiple bands of 85-98 kDa (fragments N1-N4),
whilst anti-SulfFP2B antibody detected multiple bands of 39-51 kDa (fragments C1-C2
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and M1-M2; Fig. 2A). The sum of the apparent molecular masses of the fragments
detected by anti-SulfFP2A and anti-SulfFP2B antibody was close to the size of the full-
length protein (~130 kDa), indicating that SulfFP2 protein was largely cleaved into the
N- and C-terminal fragments. Anti- SulfFP2A antibody also detected faint bands of 51
kDa and 43 kDa, indicating that a fraction of the polyclonal antibody reacted with the
C-terminal fragments (C1 and M1 fragments).These data were compatible with previous
findings that western blotting detected the N-terminal (72-75 kDa) or C-terminal (40-50
kDa) fragments of human Sulf1 or Sulf2 in the conditioned media of Chinese Hamster
Ovary cells, 293 cells, or HT1080 cells transfected with Sulf1 or Sulf2 [9, 16-17, 22] in
the conditioned medium of some pancreas tumor cells expressing endogenous Sulf2
[23] or in the cartilage of patients with osteoarthritis [24].
Interestingly, anti-SulfFP2B antibody detected more bands than anti-Myc antibody
did: both anti-SulfFP2B and anti-Myc antibody detected bands of 51 kDa and 48 kDa
(fragments C1 and C2), whereas anti-SulfFP2B but not anti-Myc antibody detected
smaller bands of 43 kDa and 39 kDa (fragments M1 and M2; Fig. 2A). These data
indicated that the 43/39-kDa fragments lacked the C-terminal portion recognized by
anti-Myc. It was also notable that the 20-kDa band (fragment C3) detected by anti-Myc
was not detected by anti-SulfFP2B and that the size difference between 51/48 kDa and
43/39 kDa was close to the size of the C3 fragment after N-glycosidase F treatment.
Taken together, these findings indicate that SulfFP2 was cleaved into the N- and C-
terminal fragments in the hydrophilic domain, and that the C-terminal fragments were
further cleaved at an unidentified site near the C terminus (Fig. 2B).
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Cleavage of SulfFP2 by furin-like PCs
Given that SulfFP2 was cleaved at 2 sites (Arg543 and Arg570) that matched the
consensus sequence for the cleavage by furin-type PCs, SulfFP2 likely underwent
cleavage by these endopeptidases. To examine this, we tested whether introduction of a
point mutation in the cleavage motifs or treatment with a furin inhibitor blocked the
cleavage. In these experiments, we performed western blotting of SulfFP2 after N-
glycosidase F treatment because it was easier to identify the detected bands by referring
to the calculated molecular masses of the putative SulfFP2 fragments.
We first tested a mutant SulfFP2 protein in which arginine at 543 was converted to
glycine (termed SulfFP2 (R543G)). Western blot analysis by anti-Myc antibody
detected 2 bands of 41 kDa and 38 kDa (fragments C1 and C2) in SulfFP2-transfected
cells, whereas in SulfFP2 (R543G)-transfected cells, the 41-kDa band disappeared, the
38-kDa band remained unchanged, and a 102-kDa band appeared (Fig. 3A). Similarly,
in a mutant in which arginine at 570 was converted to glycine (termed SulfFP2
(R570G)), the 38-kDa band disappeared whilst the 41-kDa band remained unchanged
(data not shown). These results demonstrated that the 41-kDa and 38-kDa fragments
derived from the cleavage at Arg543 and Arg570, respectively, and that the processing
required the furin/PC cleavage motifs.
We next examined the effect of a furin/PC inhibitor, dec-RVKR-CMK. It
specifically inactivates PCs by irreversibly modifying the active sites of the enzymes
[25]. Treatment with this inhibitor resulted in selective loss of the 38-kDa band and
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appearance of the 102-kDa band (Fig. 3B), indicating that the cleavage at Arg570 was
sensitive to dec-RVKR-CMK, whereas the cleavage at Arg543 was relatively resistant.
The combination of the R543G mutation and the inhibitor treatment abolished all the
processed fragments (Fig. 3B), indicating that major cleavage of SulfFP2 occurred at
these 2 sites. We also performed western blotting of the same samples with a mixture of
anti-SulfFP2A and anti-SulfFP2B antibodies. This revealed that 2 bands of 33 kDa and
31 kDa (fragments M1 and M2) were detected in addition to the N-terminal (55-65
kDa) and the C-terminal (38 kDa and 41 kDa) fragments (Fig. 3B). The 33-kDa band
disappeared upon introduction of the R543G mutation, whereas the 31-kDa bands
disappeared upon treatment with dec-RVKR-CMK (Fig. 3B), indicating that they
derived from the cleavage at Arg543 and Arg570, respectively.
Sulfatase activity of the uncleavable SulfFP2
Finally, we tested whether the proteolytic cleavage was necessary for activating
SulfFP2. To avoid the possibility of a furin inhibitor influencing sulfatase activity by
acting on unknown targets, we decided not to use the inhibitor and instead to use
SulfFP2 mutants SulfFP2 (R543G) and SulfFP2 (R570G) and a double mutant SulfFP2
(R543G/R570G). We co-transfected 293EBNA cells with Sumf1 because Sumf1
increased the SulfFP2 activity (data not shown). We confirmed that cleavages at both
Arg543 and Arg570 were abolished in SulfFP2 (R543G/R570G) (data not shown). When
sulfatase activity in the conditioned medium was measured using a fluorogenic substrate
4-MUS at pH 7.4, all SulfFP2 mutants showed sulfatase activity comparable to that of
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wild-type SulfFP2 (Fig. 4A). Next, we measured endosulfatase activity using heparin as
a substrate. After heparin was incubated with the conditioned medium, it was
completely digested by a mixture of heparinases, and the resultant unsaturated
disaccharides were analyzed by reversed-phase ion-pair chromatography. SulfFP2 led to
the decrease of ΔUA2S-GlcNS6S with a concomitant increase of ΔUA2S-GlcNS (Fig.
4B), indicating that SulfFP2 hydrolyzed the 6-O-sulfate in the trisulfated disaccharide
units in heparin, as reported previously [9, 12, 14]. SulfFP2 (R543G), SulfFP2 (R570G),
and SulfFP2 (R543G/R570G) showed endosulfatase activity comparable to that of wild-
type SulfFP2. Thus, proteolytic cleavage was not indispensable for activation of
SulfFP2.
The hydrophilic domain of Sulfs is a unique structure that is absent in other
sulfatases [13]. Deletion studies showed that this domain in quail Sulf1 was required to
anchor Sulf protein on the cell surface [8]. In addition, this domain, which carries many
basic amino acids, bound to negatively-charged heparin/HS and was required for
sulfatase activity [12, 22, 26]. We found that proteolytic processing of SulfFP2 occurred
in its hydrophilic domain. Therefore, although the uncleavable SulfFP2 mutants showed
endosulfatase activity comparable to wild-type SulfFP2, proteolytic cleavage may
influence the functions of SulfFP2 in physiological environments. Future studies are
required to elucidate the role of Sulf processing in vivo.
Conclusion
In this study, we demonstrated that SulfFP2 protein was proteolytically cleaved at
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Arg543 and Arg570 in the hydrophilic domain. Both sites resided in the consensus
sequence for the cleavage by furin-type PCs. Cleavages at Arg570 and Arg543 were
sensitive and relatively resistant to dec-RVKR-CMK, respectively. Uncleavable SulfFP2
showed sulfatase activity, suggesting that proteolytic cleavage was not indispensable for
activation of SulfFP2.
Note added in proof. During the preparation of this manuscript, similar results for
human Sulf1 and Sulf2 were reported [26].
Acknowledgements
This work was supported by Grants-in-Aid for Scientific Research on Priority Areas and
the 21st century COE program from the Ministry of Education, Culture, Sports, Science,
and Technology of Japan, and by grants from the NOVARTIS Foundation (Japan), the
Inamori Foundation, the Uehara Memorial Foundation, and the Mizutani Foundation for
Glycoscience. The authors thank J. Miyazaki for a pCAGGS vector and F. Miyamasu
for critical reading of the manuscript.
16
References
[1] U. Lindahl, M. Kusche-Gullberg, L. Kjellen, Regulated diversity of heparan sulfate,
J. Biol. Chem. 273 (1998) 24979-24982.
[2] N. Perrimon, M. Bernfield, Specificities of heparan sulphate proteoglycans in
developmental processes, Nature 404 (2000) 725-728.
[3] J. Turnbull, A. Powell, S. Guimond, Heparan sulfate: decoding a dynamic
multifunctional cell regulator, Trends Cell Biol. 11 (2001) 75-82.
[4] J. D. Esko, S. B. Selleck, Order out of chaos: assembly of ligand binding sites in
heparan sulfate, Annu. Rev. Biochem. 71 (2002) 435-471.
[5] G. Parenti, G. Meroni, A. Ballabio, The sulfatase gene family, Curr. Opin. Genet.
Dev. 7 (1997) 386-391.
[6] T. Dierks, B. Schmidt, L. V. Borissenko, J. Peng, A. Preusser, M. Mariappan, K. von
Figura, Multiple sulfatase deficiency is caused by mutations in the gene encoding the
human C(alpha)-formylglycine generating enzyme, Cell 113 (2003) 435-444.
[7] M. P. Cosma, S. Pepe, I. Annunziata, R. F. Newbold, M. Grompe, G. Parenti, A.
Ballabio, The multiple sulfatase deficiency gene encodes an essential and limiting factor
for the activity of sulfatases, Cell 113 (2003) 445-456.
[8] G. K. Dhoot, M. K. Gustafsson, X. Ai, W. Sun, D. M. Standiford, C. P. Emerson, Jr.,
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase,
Science 293 (2001) 1663-1666.
[9] M. Morimoto-Tomita, K. Uchimura, Z. Werb, S. Hemmerich, S. D. Rosen, Cloning
and characterization of two extracellular heparin-degrading endosulfatases in mice and
17
humans, J. Biol. Chem. 277 (2002) 49175-49185.
[10] T. Ohto, H. Uchida, H. Yamazaki, K. Keino-Masu, A. Matsui, M. Masu,
Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid
plexus and cartilage, Genes Cells 7 (2002) 173-185.
[11] S. Nagamine, S. Koike, K. Keino-Masu, M. Masu, Expression of a heparan sulfate
remodeling enzyme, heparan sulfate 6-O-endosulfatase sulfatase FP2, in the rat nervous
system, Brain Res. Dev. Brain Res. 159 (2005) 135-143.
[12] X. Ai, A. T. Do, M. Kusche-Gullberg, U. Lindahl, K. Lu, C. P. Emerson, Jr.,
Substrate specificity and domain functions of extracellular heparan sulfate 6-O-
endosulfatases, QSulf1 and QSulf2, J. Biol. Chem. 281 (2006) 4969-4976.
[13] W. C. Lamanna, I. Kalus, M. Padva, R. J. Baldwin, C. L. Merry, T. Dierks, The
heparanome--the enigma of encoding and decoding heparan sulfate sulfation, J.
Biotechnol. 129 (2007) 290-307.
[14] X. Ai, A. T. Do, O. Lozynska, M. Kusche-Gullberg, U. Lindahl, C. P. Emerson, Jr.,
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans
to promote Wnt signaling, J. Cell Biol. 162 (2003) 341-351.
[15] J. Lai, J. Chien, J. Staub, R. Avula, E. L. Greene, T. A. Matthews, D. I. Smith, S. H.
Kaufmann, L. R. Roberts, V. Shridhar, Loss of HSulf-1 up-regulates heparin-binding
growth factor signaling in cancer, J. Biol. Chem. 278 (2003) 23107-23117.
[16] K. Uchimura, M. Morimoto-Tomita, A. Bistrup, J. Li, M. Lyon, J. Gallagher, Z.
Werb, S. D. Rosen, HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively
mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and
18
SDF-1, BMC Biochem. 7 (2006) 2.
[17] W. C. Lamanna, M. A. Frese, M. Balleininger, T. Dierks, Sulf loss influences N-, 2-
O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates
fibroblast growth factor signaling, J. Biol. Chem. 283 (2008) 27724-27735.
[18] K. Nakayama, Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in
processing of a wide variety of precursor proteins, Biochem. J. 327 (1997) 625-635.
[19] G. Thomas, Furin at the cutting edge: from protein traffic to embryogenesis and
disease, Nat. Rev. Mol. Cell. Biol. 3 (2002) 753-766.
[20] P. Duckert, S. Brunak, N. Blom, Prediction of proprotein convertase cleavage sites,
Protein Eng. Des. Sel. 17 (2004) 107-112.
[21] H. Toyoda, A. Kinoshita-Toyoda, S. B. Selleck, Structural analysis of
glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that
tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate
in vivo, J. Biol. Chem. 275 (2000) 2269-2275.
[22] M. A. Frese, F. Milz, M. Dick, W. C. Lamanna, T. Dierks, Characterization of the
human sulfatase Sulf1 and its high-affinity heparin/heparan sulfate interaction domain, J.
Biol. Chem. 284 (2009) 28033-28044.
[23] R. Nawroth, A. van Zante, S. Cervantes, M. McManus, M. Hebrok, S. D. Rosen,
Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate
growth and tumorigenicity of human pancreatic cancer cells, PLoS One 2 (2007) e392.
[24] S. Otsuki, N. Taniguchi, S. P. Grogan, D. D'Lima, M. Kinoshita, M. Lotz,
Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and
19
osteoarthritic articular cartilage, Arthritis Res. Ther. 10 (2008) R61.
[25] W. Garten, S. Hallenberger, D. Ortmann, W. Schafer, M. Vey, H. Angliker, E. Shaw,
H. D. Klenk, Processing of viral glycoproteins by the subtilisin-like endoprotease furin
and its inhibition by specific peptidylchloroalkylketones, Biochimie 76 (1994) 217-225.
[26] R. Tang, S. Rosen, Functional consequences of the subdomain organization of the
Sulfs, J. Biol. Chem. 284 (2009) 21505-21514.
20
Figure legends
Figure 1. Cleavage sites of SulfFP2 protein. (A) Schematic structure of rat SulfFP2.
The black boxes at the N- and C-termini indicate the signal sequence (SS) and a Myc-
His tag, respectively. The gray box indicates the hydrophilic domain. Arrows indicate
proteolytic cleavage sites. Underlines indicate the consensus sequence for cleavage by
furin-type PCs. (B-C) Amino acid sequence alignment of vertebrate Sulf2. N-terminal
sequences (B; 1-40 of rat SulfFP2) and the sequences in the hydrophilic domain (C;
536-574 of rat SulfFP2) are shown. Shading indicates arginine (R) and lysine (K)
residues conserved among species. Arrows indicate proteolytic cleavage sites
determined by Edman degradation sequencing.
Figure 2. Proteolytic cleavage of SulfFP2 protein. (A) Western blot of SulfFP2 protein.
The cell lysate and the conditioned medium of mock- or pCEP4-SulfFP2-MycHis-
transfected 293EBNA cells were analyzed by western blotting with anti-Myc, anti-
SulfFP2A, or anti-SulfFP2B antibody. Sizes of the markers (kDa) are shown on the left.
The names of fragments shown on the right are indicated in (B). (B) Schematic
structures of the putative SulfFP2 fragments. The sizes of the bands (kDa) detected by
western blotting (WB) with or without N-glycosidase F (NGase) treatment and
calculated molecular masses (Mr) for each fragment are shown on the right. The gray
regions indicate the sequences used to make anti-SulfFP2A or anti-SulfFP2B antibodies.
Arrows indicate the cleavage site determined by Edman degradation sequencing,
whereas the dotted arrow indicates the putative cleavage site. Dots over boxes indicate
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putative N-glycosylation sites.
Figure 3. Effects of a furin inhibitor and a point mutation in the cleavage motif on
SulfFP2 processing. 293EBNA cells were transfected with pCEP4-SulfFP2-MycHis or
pCEP4-SulfFP2 (R543G)-MycHis and cultured with or without 10 µM dec-RVKR-
CMK. The conditioned media were concentrated, treated with N-glycosidase F, and
subjected to western blotting with anti-Myc antibody (A) or with anti-SulfFP2A and
anti-SulfFP2B antibodies (B). Sizes of the markers (kDa) are shown on the left. Names
of the fragments shown on the right are indicated in Figure 2B.
Figure 4 Sulfatase activity of SulfFP2 and its mutants. (A) Sulfatase activity measured
using 4-MUS. (B) Endosulfatase activity measured using heparin as a substrate. Heparin
was incubated with SulfFP2 or its mutants and then subjected to disaccharide analysis.
Molar percentages of 8 unsaturated disaccharides are shown. The conditioned medium
from the β-galactosidase-transfected cells was used as a negative control. Averages
from 3 independent experiments are shown. The bars indicate standard deviation.




